Pemigatinib and Immune Checkpoint Inhibitor Treated FGFR1/2/3 Alteration Advanced Solid Tumor

Clinical trial NCT06551896 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06551896
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Urothelial Carcinoma Breast Neoplasms Lung Cancer Gastric Cancer Soft Tissue Sarcoma Other Carcinoma

Start date: 2024-08-15
Primary completion: 2026-07-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.